ST Sinopep, Vazyme and others establish a new biopharmaceutical company
According to the Qichacha APP, recently, Nanjing Sinopep Biopharmaceutical Co., Ltd. was established with a registered capital of 20 million yuan. The business scope includes: research and development of bio-based material technology; research and development of industrial enzyme preparations; research and development of biological feed; research and development of biochemical products technology, etc. Qichacha's equity penetration shows that the company is jointly held by Sinopep and Vazyme
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments